Reticular pseudodrusen: A critical phenotype in age-related macular degeneration
Reticular pseudodrusen (RPD), or subretinal drusenoid deposits (SDD), refer to distinct lesions that occur in the subretinal space. Over the past three decades, their presence in association with age-related macular degeneration (AMD) has become increasingly recognized, especially as RPD have become...
Gespeichert in:
Veröffentlicht in: | Progress in retinal and eye research 2022-05, Vol.88, p.101017-101017, Article 101017 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 101017 |
---|---|
container_issue | |
container_start_page | 101017 |
container_title | Progress in retinal and eye research |
container_volume | 88 |
creator | Wu, Zhichao Fletcher, Erica L. Kumar, Himeesh Greferath, Ursula Guymer, Robyn H. |
description | Reticular pseudodrusen (RPD), or subretinal drusenoid deposits (SDD), refer to distinct lesions that occur in the subretinal space. Over the past three decades, their presence in association with age-related macular degeneration (AMD) has become increasingly recognized, especially as RPD have become more easily distinguished with newer clinical imaging modalities. There is also an increasing appreciation that RPD appear to be a critical AMD phenotype, where understanding their pathogenesis will provide further insights into the processes driving vision loss in AMD. However, key barriers to understanding the current evidence related to the independent impact of RPD include the heterogeneity in defining their presence, and failure to account for the confounding impact of the concurrent presence and severity of AMD pathology. This review thus critically discusses the current evidence on the prevalence and clinical significance of RPD and proposes a clinical imaging definition of RPD that will help move the field forward in gathering further key knowledge about this critical phenotype. It also proposes a putative mechanism for RPD formation and how they may drive progression to vision loss in AMD, through examining current evidence and presenting novel findings from preclinical and clinical studies. |
doi_str_mv | 10.1016/j.preteyeres.2021.101017 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2596017299</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1350946221000781</els_id><sourcerecordid>2596017299</sourcerecordid><originalsourceid>FETCH-LOGICAL-c374t-b94c0fe86655084e3b6df9b9637e2abb5803a76494f2abb7898fae8f59c466093</originalsourceid><addsrcrecordid>eNqFkMlOwzAQhi0EoqXwCihHLil2vCTmVio2qRIIwdly7ElxlQ07QerbkygFjpxm-_8ZzYdQRPCSYCKud8vWQwd78BCWCU7I2MYkPUJzkqU0JoLy4yGnHMeSiWSGzkLYYYwFlvwUzShLeSKJmKOXV-ic6UvtozZAbxvr-wD1TbSKjHfDSJdR-wF10-1biFwd6S3EHkrdgY0qPTktbKEGrzvX1OfopNBlgItDXKD3-7u39WO8eX54Wq82saEp6-JcMoMLyITgHGcMaC5sIXMpaAqJznOeYapTwSQrxjLNZFZoyAouDRPDF3SBrqa9rW8-ewidqlwwUJa6hqYPKuFSDEQSOUqzSWp8E4KHQrXeVdrvFcFq5Kl26o-nGnmqiedgvTxc6fMK7K_xB-AguJ0EMPz65cCrYBzUBqzzYDplG_f_lW-JvIye</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2596017299</pqid></control><display><type>article</type><title>Reticular pseudodrusen: A critical phenotype in age-related macular degeneration</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Wu, Zhichao ; Fletcher, Erica L. ; Kumar, Himeesh ; Greferath, Ursula ; Guymer, Robyn H.</creator><creatorcontrib>Wu, Zhichao ; Fletcher, Erica L. ; Kumar, Himeesh ; Greferath, Ursula ; Guymer, Robyn H.</creatorcontrib><description>Reticular pseudodrusen (RPD), or subretinal drusenoid deposits (SDD), refer to distinct lesions that occur in the subretinal space. Over the past three decades, their presence in association with age-related macular degeneration (AMD) has become increasingly recognized, especially as RPD have become more easily distinguished with newer clinical imaging modalities. There is also an increasing appreciation that RPD appear to be a critical AMD phenotype, where understanding their pathogenesis will provide further insights into the processes driving vision loss in AMD. However, key barriers to understanding the current evidence related to the independent impact of RPD include the heterogeneity in defining their presence, and failure to account for the confounding impact of the concurrent presence and severity of AMD pathology. This review thus critically discusses the current evidence on the prevalence and clinical significance of RPD and proposes a clinical imaging definition of RPD that will help move the field forward in gathering further key knowledge about this critical phenotype. It also proposes a putative mechanism for RPD formation and how they may drive progression to vision loss in AMD, through examining current evidence and presenting novel findings from preclinical and clinical studies.</description><identifier>ISSN: 1350-9462</identifier><identifier>EISSN: 1873-1635</identifier><identifier>DOI: 10.1016/j.preteyeres.2021.101017</identifier><identifier>PMID: 34752916</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Age-related macular degeneration ; Drusen ; Fluorescein Angiography - methods ; Humans ; Macular Degeneration - epidemiology ; Phenotype ; reticular pseudodrusen ; Retina - pathology ; Retinal Drusen - genetics ; Risk Factors ; Subretinal drusenoid deposits ; Tomography, Optical Coherence - methods</subject><ispartof>Progress in retinal and eye research, 2022-05, Vol.88, p.101017-101017, Article 101017</ispartof><rights>2021 Elsevier Ltd</rights><rights>Copyright © 2021 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c374t-b94c0fe86655084e3b6df9b9637e2abb5803a76494f2abb7898fae8f59c466093</citedby><cites>FETCH-LOGICAL-c374t-b94c0fe86655084e3b6df9b9637e2abb5803a76494f2abb7898fae8f59c466093</cites><orcidid>0000-0001-9169-5335 ; 0000-0002-9441-4356</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1350946221000781$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34752916$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wu, Zhichao</creatorcontrib><creatorcontrib>Fletcher, Erica L.</creatorcontrib><creatorcontrib>Kumar, Himeesh</creatorcontrib><creatorcontrib>Greferath, Ursula</creatorcontrib><creatorcontrib>Guymer, Robyn H.</creatorcontrib><title>Reticular pseudodrusen: A critical phenotype in age-related macular degeneration</title><title>Progress in retinal and eye research</title><addtitle>Prog Retin Eye Res</addtitle><description>Reticular pseudodrusen (RPD), or subretinal drusenoid deposits (SDD), refer to distinct lesions that occur in the subretinal space. Over the past three decades, their presence in association with age-related macular degeneration (AMD) has become increasingly recognized, especially as RPD have become more easily distinguished with newer clinical imaging modalities. There is also an increasing appreciation that RPD appear to be a critical AMD phenotype, where understanding their pathogenesis will provide further insights into the processes driving vision loss in AMD. However, key barriers to understanding the current evidence related to the independent impact of RPD include the heterogeneity in defining their presence, and failure to account for the confounding impact of the concurrent presence and severity of AMD pathology. This review thus critically discusses the current evidence on the prevalence and clinical significance of RPD and proposes a clinical imaging definition of RPD that will help move the field forward in gathering further key knowledge about this critical phenotype. It also proposes a putative mechanism for RPD formation and how they may drive progression to vision loss in AMD, through examining current evidence and presenting novel findings from preclinical and clinical studies.</description><subject>Age-related macular degeneration</subject><subject>Drusen</subject><subject>Fluorescein Angiography - methods</subject><subject>Humans</subject><subject>Macular Degeneration - epidemiology</subject><subject>Phenotype</subject><subject>reticular pseudodrusen</subject><subject>Retina - pathology</subject><subject>Retinal Drusen - genetics</subject><subject>Risk Factors</subject><subject>Subretinal drusenoid deposits</subject><subject>Tomography, Optical Coherence - methods</subject><issn>1350-9462</issn><issn>1873-1635</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMlOwzAQhi0EoqXwCihHLil2vCTmVio2qRIIwdly7ElxlQ07QerbkygFjpxm-_8ZzYdQRPCSYCKud8vWQwd78BCWCU7I2MYkPUJzkqU0JoLy4yGnHMeSiWSGzkLYYYwFlvwUzShLeSKJmKOXV-ic6UvtozZAbxvr-wD1TbSKjHfDSJdR-wF10-1biFwd6S3EHkrdgY0qPTktbKEGrzvX1OfopNBlgItDXKD3-7u39WO8eX54Wq82saEp6-JcMoMLyITgHGcMaC5sIXMpaAqJznOeYapTwSQrxjLNZFZoyAouDRPDF3SBrqa9rW8-ewidqlwwUJa6hqYPKuFSDEQSOUqzSWp8E4KHQrXeVdrvFcFq5Kl26o-nGnmqiedgvTxc6fMK7K_xB-AguJ0EMPz65cCrYBzUBqzzYDplG_f_lW-JvIye</recordid><startdate>202205</startdate><enddate>202205</enddate><creator>Wu, Zhichao</creator><creator>Fletcher, Erica L.</creator><creator>Kumar, Himeesh</creator><creator>Greferath, Ursula</creator><creator>Guymer, Robyn H.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9169-5335</orcidid><orcidid>https://orcid.org/0000-0002-9441-4356</orcidid></search><sort><creationdate>202205</creationdate><title>Reticular pseudodrusen: A critical phenotype in age-related macular degeneration</title><author>Wu, Zhichao ; Fletcher, Erica L. ; Kumar, Himeesh ; Greferath, Ursula ; Guymer, Robyn H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c374t-b94c0fe86655084e3b6df9b9637e2abb5803a76494f2abb7898fae8f59c466093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Age-related macular degeneration</topic><topic>Drusen</topic><topic>Fluorescein Angiography - methods</topic><topic>Humans</topic><topic>Macular Degeneration - epidemiology</topic><topic>Phenotype</topic><topic>reticular pseudodrusen</topic><topic>Retina - pathology</topic><topic>Retinal Drusen - genetics</topic><topic>Risk Factors</topic><topic>Subretinal drusenoid deposits</topic><topic>Tomography, Optical Coherence - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wu, Zhichao</creatorcontrib><creatorcontrib>Fletcher, Erica L.</creatorcontrib><creatorcontrib>Kumar, Himeesh</creatorcontrib><creatorcontrib>Greferath, Ursula</creatorcontrib><creatorcontrib>Guymer, Robyn H.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Progress in retinal and eye research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wu, Zhichao</au><au>Fletcher, Erica L.</au><au>Kumar, Himeesh</au><au>Greferath, Ursula</au><au>Guymer, Robyn H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reticular pseudodrusen: A critical phenotype in age-related macular degeneration</atitle><jtitle>Progress in retinal and eye research</jtitle><addtitle>Prog Retin Eye Res</addtitle><date>2022-05</date><risdate>2022</risdate><volume>88</volume><spage>101017</spage><epage>101017</epage><pages>101017-101017</pages><artnum>101017</artnum><issn>1350-9462</issn><eissn>1873-1635</eissn><abstract>Reticular pseudodrusen (RPD), or subretinal drusenoid deposits (SDD), refer to distinct lesions that occur in the subretinal space. Over the past three decades, their presence in association with age-related macular degeneration (AMD) has become increasingly recognized, especially as RPD have become more easily distinguished with newer clinical imaging modalities. There is also an increasing appreciation that RPD appear to be a critical AMD phenotype, where understanding their pathogenesis will provide further insights into the processes driving vision loss in AMD. However, key barriers to understanding the current evidence related to the independent impact of RPD include the heterogeneity in defining their presence, and failure to account for the confounding impact of the concurrent presence and severity of AMD pathology. This review thus critically discusses the current evidence on the prevalence and clinical significance of RPD and proposes a clinical imaging definition of RPD that will help move the field forward in gathering further key knowledge about this critical phenotype. It also proposes a putative mechanism for RPD formation and how they may drive progression to vision loss in AMD, through examining current evidence and presenting novel findings from preclinical and clinical studies.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>34752916</pmid><doi>10.1016/j.preteyeres.2021.101017</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-9169-5335</orcidid><orcidid>https://orcid.org/0000-0002-9441-4356</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1350-9462 |
ispartof | Progress in retinal and eye research, 2022-05, Vol.88, p.101017-101017, Article 101017 |
issn | 1350-9462 1873-1635 |
language | eng |
recordid | cdi_proquest_miscellaneous_2596017299 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Age-related macular degeneration Drusen Fluorescein Angiography - methods Humans Macular Degeneration - epidemiology Phenotype reticular pseudodrusen Retina - pathology Retinal Drusen - genetics Risk Factors Subretinal drusenoid deposits Tomography, Optical Coherence - methods |
title | Reticular pseudodrusen: A critical phenotype in age-related macular degeneration |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T19%3A47%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reticular%20pseudodrusen:%20A%20critical%20phenotype%20in%20age-related%20macular%20degeneration&rft.jtitle=Progress%20in%20retinal%20and%20eye%20research&rft.au=Wu,%20Zhichao&rft.date=2022-05&rft.volume=88&rft.spage=101017&rft.epage=101017&rft.pages=101017-101017&rft.artnum=101017&rft.issn=1350-9462&rft.eissn=1873-1635&rft_id=info:doi/10.1016/j.preteyeres.2021.101017&rft_dat=%3Cproquest_cross%3E2596017299%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2596017299&rft_id=info:pmid/34752916&rft_els_id=S1350946221000781&rfr_iscdi=true |